IMCR - CIK 0001671927
Immunocore Holdings plc (IMCR) reported revenue of $400.02M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $400.02M | +29.0% |
| FY 2024 | $310.20M | +24.4% |
| FY 2023 | $249.43M | +43.1% |
| FY 2022 | $174.36M | +377.9% |
| FY 2021 | $36.48M | - |
Immunocore Holdings plc (IMCR) reported revenue of $400.02M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2021 and fiscal 2025, Immunocore Holdings plc's revenue grew from $36.48M to $400.02M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.